NEUROPEAK
LIVE

Serial Number

79188020

Owner

FRAU PHARMA S.R.L.

Attorney

Keith A. Weltsch

Filing Date

Sep 22, 2015

Add to watchlist:

No watchlists yet
View on USPTO

NEUROPEAK Trademark

Serial Number: 79188020 • Registration: 5211312

NEUROPEAK is a trademark filed by FRAU PHARMA S.R.L. on September 22, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods). The application is currently registered and active.

Owner Contact Info

FRAU PHARMA S.R.L. (5 trademarks)

Via Trivulzina, 13/1

Entity Type: 16

Trademark Details

Filing Date

September 22, 2015

Registration Date

May 30, 2017

Published for Opposition

March 14, 2017

Goods & Services

Chemical additives for use in the manufacture of food; emulsifiers for use in the manufacture of food; [ enzymes for use in the manufacture of nutraceuticals; enzymes for the food industry; enzyme preparations for the food industry; chemical substances for preserving foodstuffs; chemical additives for use as binding agents for foodstuffs; fatty acids and omega 3 fatty acids for use in the preparation of food and supplements for human and animal use; amino acids for industrial purposes; protein, namely, protein for industrial use, protein in raw material form for scientific and medical research; vitamins for use in manufacture; vitamins for use in the manufacture of food products; vitamins for use in the manufacture of food supplements; vitamins for use in the manufacture of pharmaceuticals; carbohydrates used as an ingredient in nutraceuticals; chemicals in the form of water soluble oils for use in industry; ] lipids for use in manufacture; lecithin for the food industry; lecithin for use in manufacture; chemical additives for use in the manufacture of pharmaceuticals, food, dietary supplements, namely, phospholipids, saturated and non-saturated fatty acids, omega-3 and omega-6, phosphatidic acid, [ palmitoylethanolamide, folic acid, methyltetrahydrofolate and other derivatives of folic acid, inositol, chiro-inositol, and ] inositol phosphates; chemical additives for use in the manufacture of pharmaceuticals, food, supplements and dietetic substances for human beings and animals; chemical substances for preparation of reinforced food; chemical compounds for use in the manufacture of pharmaceuticals, food, supplements and dietetic substances for human beings and animals; vitamins for use in the manufacture of pharmaceuticals, food, supplements and dietetic substances for human beings and animals; chemical additives and vitamins for use in the manufacture of pharmaceuticals, food, supplements and dietetic substances for human beings and animals, namely, [ amino acids, protein, micronutrients, mineral salts, carbohydrate, ] oils, lipids, phospholipids, fats, [ inorganic acids, ] saturated and non-saturated fatty acids, omega-3 and omega-6, phosphatidic acid, [ palmitoylethanolamide, folic acid, methyltetrahydrofolate and other derivatives of folic acid, inositol, chiro-inositol, ] inositol phosphates; phosphatidylserine being a chemical additive for use in the manufacture of pharmaceuticals, food, dietary supplements; [ carbohydrates used as an ingredient in the manufacture of nutraceuticals; proteins for the food industry; proteins for use in manufacture; protein for industrial purposes; ] phosphatidylinositol being a chemical additive for use in the manufacture of pharmaceuticals, food, dietary supplements [ ; n-oleoylethanolamine being a chemical additive for use in the manufacture of pharmaceuticals, food, dietary supplements; myo-inositol being a chemical additive for use in the manufacture of pharmaceuticals, food, dietary supplements ]

[ Food supplements; dietary supplements; dietary supplements consisting of amino acids; dietary supplements consisting of trace elements; enzyme dietary supplements; mineral food supplements; dietary supplements for humans; animal feed supplements for veterinary purposes; anti-oxidants for use as dietary supplements; dietary supplements consisting of amino acids, minerals and trace elements; dietary supplements consisting of amino acids for medical purposes; dietary supplements consisting of minerals for medical purposes; nutritional supplements, containing omega 3 fatty acids; medical and veterinary preparations in the nature of vitamin and mineral preparations, consisting primarily of fatty acids and/or omega 3; dietary and food supplements for medical and veterinary purposes deriving from edible oils and fats; amino acids for medical or veterinary purposes; food supplements consisting of amino acids; vitamins and vitamin preparations; dietary supplements consisting of vitamins; health food supplements made principally of vitamins; vitamin supplements; lecithin for medical purposes as food additives; nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables; sodium salts for medical purposes; medicinal oils; food supplements consisting of minerals; food supplements consisting of trace elements; nutraceuticals for therapeutic purposes, namely, nutraceuticals for the treatment of brain health, inflammation, cancer; nutraceuticals for use as dietary supplements; pharmaceutical preparations for activating cellular function; amino acids for medical purposes; amino acids for veterinary purposes; protein supplements for animals; protein dietary supplements; vitamins; baby vitamins; vitamin preparations; ferments for pharmaceutical purposes; enzymes for medical purposes; candy, medicated; dietetic foods, namely, pasta, crackers adapted for medical purposes; linseed dietary supplements; wheat germ dietary supplements; royal jelly dietary supplements; pollen dietary supplements; lacteal flour for babies; food for babies; powdered milk for babies; enzymes for veterinary purposes; dietary supplements for animals; by-products of the processing of cereals for dietetic or medical purposes; food supplements containing Phospholipids, phosphatidilserine, phosphatidic acid, phosphatidylinositol, palmitoylethanolamide, n-oleoylethanolamine, folic acid, methyltetrahydrofolate, inositol, myo-inositol and chiro- inositol; dietary supplements containing phospholipids, phosphatidilserine, phosphatidic acid, phosphatidylinositol, palmitoylethanolamide, n-oleoylethanolamine, folic acid, methyltetrahydrofolate, inositol, myo-inositol and chiroinositol; medical food containing phosphatidilserine phosphatidic acid, phosphatidylinositol, palmitoylethanolamide, n-oleylethanolamide, folic acid, methyltetrahydrofolic acid, myo-inositol, chiro inositol ]

[ Animal fats for food; blended oil for food; hydrogenated oils for food; vegetable oils for food; blended oil for alimentary purposes; blended oil, edible oil, olive oil rich in omega 3; vitamin-enriched milk; olive oil for food; edible oils; lecithin for culinary purposes as food additives for non-industrial use; processed edible seaweed; compotes; charcuterie; seaweed extracts for food; soya milk; yoghurt; cheese; fermented milk; goat milk; milk curd; milk powder; processed nuts; condensed milk; food products made from meat, fish, poultry and game, namely, meat, fish, poultry, game with added phospholipids, phosphatidilserine, phosphatidic acid, osphatidylinositol, palmitoylethanolamide, n-oleoylethanolamine, folic acid, methyltetrahydrofolate, inositol, myo-inositol and chiro-inositol; food products made from fruits and vegetables, namely, dried fruits and vegetables, preserved fruits and vegetables, cooked fruits and vegetables with added phospholipids, phosphatidilserine, phosphatidic acid, phosphatidylinositol, palmitoylethanolamide, n-oleoylethanolamine, folic acid, methyltetrahydrofolate, inositol, myo-inositol and chiro-inositol; food products made from eggs and milk, namely, eggs and milk with added phospholipids, phosphatidilserine, phosphatidic acid, phosphatidylinositol, palmitoylethanolamide, n-oleoylethanolamine, folic acid, methyltetrahydrofolate, inositol, myo-inositol and chiro-inositol; food products made from edible oils and fats, namely, edible oils and edible fats with added phospholipids, phosphatidilserine, phosphatidic acid, phosphatidylinositol, palmitoylethanolamide, n-oleoylethanolamine, folic acid, methyltetrahydrofolate, inositol, myo-inositol and chiro-inositol ]

[ Yeast extracts for human consumption; carbohydrate preparations for food, namely, flour, corn flour, bread mixes, biscotti mixes; gluten additives for culinary purposes; coffee; malt extracts used as flavorings for food and beverages; tea; iced tea; sugar; chocolate; ice cream; rusks; biscuits; muesli; flavorings, other than essential oils, for beverages; breakfast cereals; pizzas; bakery goods; rice; popcorn; soya flour; pasta; celery salt; vinegar; seasonings; starch-based thickeners for whipped cream; maize, roasted; cocoa; artificial coffee; tapioca; sago; flour; bread; pastries; frozen confectionery; confectionery made of sugar; fruit jelly being candy; edible ices; yeast; baking powder; cooking salt; mustard; sauces as condiments; spices; ice for refreshment; ice, natural or artificial; food products made from rice, flour, cereals, namely, rice, flour, cereal with added phospholipids, phosphatidilserine, phosphatidic acid, phosphatidylinositol, palmitoylethanolamide, n-oleoylethanolamine, folic acid, methyltetrahydrofolate, inositol, myo-inositol and chiro-inositol; food products being bread, pastry and confectionery with added phospholipids, phosphatidilserine, phosphatidic acid, phosphatidylinositol, palmitoylethanolamide, n-oleoylethanolamine, folic acid, methyltetrahydrofolate, inositol, myo-inositol and chiro-inositol ]

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
May 30, 2026 REM4
INTERNATIONAL REGISTRATION RENEWED
Jul 17, 2025 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Feb 8, 2025 INNP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Dec 17, 2024 INNA
GENERIC MADRID TRANSACTION SENT TO IB
Dec 12, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 12, 2024 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 29, 2024 INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 28, 2024 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Mar 28, 2024 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Mar 28, 2024 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 29, 2024 APRE
TEAS SECTION 71 & 15 RECEIVED
May 30, 2023 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 30, 2022 REM3
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 30, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 30, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 30, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 30, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 30, 2021 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 28, 2017 FINO
NOTIFICATION PROCESSED BY IB
Oct 6, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 8, 2017 FICS
FINAL DISPOSITION PROCESSED
Sep 8, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 30, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
May 30, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2017 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 22, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 22, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 9, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 19, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2017 CRFA
ASSIGNED TO LIE
Jan 13, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 14, 2016 TROA
REFUSAL PROCESSED BY IB
Jul 22, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 6, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jul 6, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 6, 2016 RFCR
APPLICATION FILING RECEIPT MAILED
Jul 6, 2016 MAFR
NON-FINAL ACTION WRITTEN
Jul 5, 2016 CNRT
ASSIGNED TO EXAMINER
Jul 2, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 1, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 30, 2016 REPR